Polyphenols are widely distributed in nature having broad spectrum of biological activities. Most of the biological effects produced by polyphenols are largely attributed to their anti-inflammatory and antioxidant potential. The current research work describes the anti-inflammatory and antioxidant potential of newly synthesized phenolic derivatives (T2, T5, T6, T7 & T8) through in silico, in vitro and in vivo approach. The docking studies were performed against NADPH oxidase (PDB ID 3A1F-) and cyclooxygenase (COX-2 with PDB ID 5KIR Homosapien) using in silico techniques. Amongst phenolic derivatives (T2, T5, T6, T7 &T8) T2 and T6 exhibited maximum binding affinity with target protein NADPH oxidase (-6.2 and -6.3 Kcal/mol respectively). However, in case of COX-2 as target protein, all the five newly synthesized phenolic derivatives showed encouraging results. In particular, T2 and T8 with binding affinity values -7.9 Kcal/mol and -8.0 Kcal/mol respectively which are promising than Ibuprofen with binding affinity -6.6 Kcal/mol. Then in vitro antioxidant potential of phenolic derivatives was analyzed through total reducing power, total antioxidant capacity and DPPH (1, 1-diphenyl-2picryl-hydrazyl) assay. T2 and T6 showed antioxidant potential with IC50 values of 25.03µg/ml and 37.21 µg/ml respectively as compared to 15.14 µg/ml with respect to ascorbic acid. In vivo anti-inflammatory potential was determined through carrageenan induced paw edema which resulted in T2 with promising percentage edema inhibition (68.64±3.34) as compare to standard piroxicam (83.84±3.87). Amongst all phenolic derivatives T2 has promising results in in silico, in vitro and in vivo studies.
INTRODUCTION
Reactive oxygen species (ROS) such as hydroxyl radical (OH • ), superoxide anion radical and superoxide anion (O2), in excess amount can contribute to wide range of disease including cardiovascular disorders and cancer (Goszczet al., 2016) . Numerous ailments including cancer, diabetes, vascular injury and heart diseases have direct pathological association with reactive oxygen species produced during inflammatory mechanisms. These free radicals may disrupt proteins, nucleic acid and other cell structures and may lead to tissue damage.
Inflammation is a multifactorial process which is primarily associated with proteins denaturation and increased vascular permeability. Inflammatory mediators are released upon injury to the cells. These inflammatory mediators leads to activation of natural body's defense cells a process termed as chemotaxis. Chronic inflammation, results into a progressive movement of cells towards the site of inflammation which resulted into destruction of the tissues. So, the use of anti-oxidant and anti-inflammatory compounds may protect the cell from damage caused by oxidative stress (Somani & Bhattachar, 2014) .
RESEARCH ARTICLE
Polyphenolic compounds impart neuro protective as well as cardioprotective roles (Vauzouret al., 2010) Phenolic compounds inhibit pro-inflammatory molecules such as nitric oxide (NO) and tumor narcotic factor alpha showing their therapeutic worth in inflammatory diseases (Sanegaret al., 2015) . Several phenolic compounds including oleuropein glycoside, vanillic acid, p-coumaric acid, syringic acid, homovanillic acid, caffeic acid, and tyrosol have inflammatory activity by inhibiting inflammatory cytokines and inflammatory eicosanoid PGE-2 (Mileset al., 2005) . Our compounds are derivatives of methoxy phenols and several derivative of methoxy phenols like 2-tert-butyl-4-methoxyphenol (BHA), 2methoxyphenols, 2,2'-dihydroxy5,5'-dimethylbiphenol and 2,2'-dihydroxy-5,5'-dimethoxy biphenol are already investigated for antioxidant and anti inflammatory activity (Kadomaet al., 2010) .
Eugenol, ferulic acid and zingeron are also reported for their antioxidant and anti-inflammatory potential. Eugenol has ability to reduce CYP2E1 activity, lipid peroxidation indices, protein oxidation and inflammatory markers they also abolish the gene expression for Cyclooxygenase-2 (Yogalakshmiet al., 2010) .
Our work reveals the antioxidant and antiinflammatory potential of newly synthesized phenolic derivatives which may be useful against the ROS induced diseases such as cancer and cardiovascular diseases. The discovery of any new molecule is pricy and time taking process, but the integration of computational screening with the experimental data can change the discovery process of new drug molecules (Ekinset al., 2007) .
MATERIALS AND METHODS

Chemistry of compounds:
These are newly synthesized methoxy phenol derivatives having 2-methoxyphenoxy ring. The main core in all the newly synthesized derivatives is same the difference is the number and presence of -OH group at the benzene ring. These derivatives are then evaluated for their antioxidant and anti-inflammatory potential using in silico, in vitro and in vivo model. Their structure and IUPAC name are mentioned in Table 1 .
Animals:
Adult male BALB/c mice weighing 20-30g were housed under controlled environmental condition (23±1°C, 55±5% humidity and a 12-h light/dark cycle) were used. Animals were given free access to standard laboratory diet and to water.
In silico Assay Target protein acquisition and preparation:
The structures of the target proteins (NADPH oxidase, NOX-2 & cyclooxygenase-2, COX-2) was acquired from Protein Data Bank as PDB format (PDB ID 3a1f-Homosapien, PDB ID 5KIR Homosapien) (Berman et al., 2000) (www.rcsb.org/pdb). These protein structures were validated through mol probity server. The accelrys discovery studio was used to remove water molecules and ligands. The UCSF chimera was used to minimize the energy of protein. The active binding sites of the proteins were viewed using PyMOL (Python molecular visualization software) (Reetz and Carballeira, 2007) . 
Ligand preparation: Thenewly synthesized phenolic derivatives structures were drawn in Marvin sketch, cleaned into 3D structures and downloaded as PDB file (Ferrandoet al., 2012) .
Docking:
The virtual screening tool was used to predict in silico interaction of phenolic derivatives (ligand) with targets. The target proteins and ligands were then converted from protein data bank (pdb) to protein data bank quality treated (pdbqt) files by addition of hydrogen and removal of water molecules. The Chimera software was used to minimize the ligand and target interaction. These prepared files were then uploaded as ligand and target protein in PyRx, a python based auto dock vina. The autogrid dimensions were calculated for NADPH oxidase (NOX-2), cyclooxygenase (COX-2) and targets were geometrically optimized and docked (Aqeel et al., 2018) .
In vitro antioxidant activity Total anti oxidant capacity:
The total antioxidant capabilities of phenolic derivatives was measured by phosphomolybdenum assay as per described by Umamaheswari and Chatterjee (2008) , with some modifications. The protocol started by adding 0.1 mL of the sample with that of 1 mL of the reagent solution. This reagent solution was prepared with 0.6 M H2SO4 and 28 mM Na3PO4 with 4 mM ammonium molybdate. Then the reaction mixture was treated with hot water (95°C) for 90 min. The reaction mixture was fully covered with silver foil to avoid direct light exposure. Then this reaction mixture was cooled and subjected to spectrophotometric analysis at 765 nm. The standard drug used was ascorbic acid. (1995) , to further confirm the presence of antioxidants. DPPH is based on the formation of yellowish diphenyl picrylhydrazine molecule when DPPH moiety is reduced by accepting a hydrogen or electron from a donor. Then 24 mg of DPPH in 100 ml methanol was prepared as stock solution and kept at 20°C. 100 mL of phenolic derivatives (T2, T5, T6, T7 & T8), (25-250 µg/ml) was mixed with DPPH (3mL) and optical density was checked at 517nm. Ascorbic acid was use as standard. The following equation was followed to determine the antioxidant capacity.
Scavenging effect (%) = (Absorbance of control -Absorbance of sample) / (Absorbance of control) X 100
In vivo anti-inflammatory activity Carrageenan-induced paw edema test: Paw edema was induced in Balb/c mice by intraplantar injection of carrageenan (0.1mL of 1% solution w/v in 0.9% saline) into sub-plantar area marked at left hind paw (100µl/paw) (Khalidet al., 2018) . These animals were divided into 8 different experimental groups (n=5) as vehicle control, negative control, positive control, treatment T2, treatment T5, treatment T6, treatment T7, treatment T8. Treatments were provided 45 min before carrageenan injection. Paw edema was evaluated at 0, 2, 4, and 6 h. The average difference of paw thickness (mm) of treated groups was compared to control groups (N.S. treated).
Statistical analysis:
The values are presented as Mean ± SEM (n=4) with superscript (a-c) letters on the bars (P value <0.05) (LSD, Least significant difference).
RESULTS
In silico assay:
In present study our newly synthesized phenolic derivatives were strongly entrapped in the active binding sites of NOX-2 and visualized through discovery studio as shown in Fig. 1 . T2 attached with amino acids Ser91, Gln142, Glu135 having distance 3.09A 0 , 2.24 A 0 and 2.38 A 0 respectively as shown in Fig. 2 . Encouraging binding affinities were also found especially with T2 and T6 (-6.2 Kcal/mol and -6.3 Kcal/mol respectively) as shown in Table 2 . Further all the phenolic derivatives were screened against COX-2 for anti-inflammatory potential. The derivatives showed promising results, especially T2 and T8 with binding energies-7.9 Kcal and -8.0 Kcal respectively which are significantly promising than Ibuprofen with binding energies -6.6 Kcal, as shown in Table 3 . All the phenolic derivatives were tightly bound at active binding sites of COX-2 ( Fig. 3) . T2 also tightly bound to enzyme COX-2 and showed hydrogen bond interaction with amino acids Phe142 and Arg376 at distance of 2.46 A 0 and 2.36 A 0 respectively as shown in Fig. 4 .
In vitro antioxidant activity Total Anti-oxidant Capacity (TAC):
On the basis of phosphomolybdenum complex formation total antioxidant capacity of phenolic derivatives was calculated. TAC was shown by all the compounds in dose dependent manner as shown in Fig. 5 . T5 showed the highest activity with level of significant of 0.001 at all the doses, followed by the T2, T6, T8 and T7. T2 also produce highly significant result at concentration of 31.25 µg/ml and 62.50 µg/ml with level of significance comparable to T5. T6 and T7 showed the comparable activity almost in all concentrations. Least significant result was also shown by T6 and T7 with level of significance of P<0.05 at concentration of 125 µg/ml and 250 µg/ml.
Total Reducing Power (TRP):
In this test depending upon the reducing power of compound, the test solution changed to different colors. Some degree of reducing power was shown by almost all the tested compounds as shown in Fig. 6 . Once again T5 (P<0.001) showed the highest reducing power (94.54%), than the other compounds (T2, 87.23%), at all the given concentration (31.25-250 µg/ml) in dose dependent manner.
DPPH assay:
In this assay again T2 showed the most significant result and yielded the greatest DPPH scavenging activity followed by the T8, T5, T6 and T7 respectively, almost in all concentrations other than the 15.75 µg/ml. At this concentration T6 also produced the most significant result (42.65%) that was comparable to T2 (43.12%). At 125 µg/ml and 250µg/ml T6 (62.45%, 71.1%) showed the comparable result with T8 (63.24%, 67.77%) with same level of significant. Similarly, at concentration of 15.75 µg/ml, 31.25 µg/ml and 62.50 µg/ml DPPH scavenging activity was almost same for T7 (37.5%, 44.34%, 51.78%) and T8 (38.91%, 44.77%, 51.56%) (Fig. 7) . In vivo anti-inflammatory activity: All phenolic derivatives were screened for anti-inflammatory potential by using carrageenan-induced paw edema test. T2 and T8 also showed significant result after 2 nd hour with percentage inhibition of 27.75 and 25.77% respectively. But after 4 th and 6 th hour results were not much significant for T8 then T2. T5 also showed comparable result with T2 after 4 th and 6 th hour but results were not statistically significant at 2 nd hour. T7 exerted the least anti-inflammatory effect for 4 th and 6 th hour as compared to other group with level of significance of less the 0.05 (Table 4) .
DISCUSSION
Interest for new anti-inflammatory and antioxidant agents have risen since past few decades as the pathophysiology of numerous age related diseases i.e. diabetes, cancer, cardiovascular related diseases, Parkinson's disease and Alzheimer's have direct link with free radicals and ROS (Rahal et al., 2014) . The chronic diseases associated with the production of free radicals, can be prevented by the inhibition of oxidative stress and ample interest in isolation and synthesis of new antioxidant and anti-inflammatory agents is emerging. This relationship between chronic diseases and inflammation has been reiterated by many authors (Hussainet al., 2016) .
The present research work emphasizes on determining the antioxidant and anti-inflammatory potential of some newly synthesized methoxy phenol derivatives. The newly synthesized methoxy phenol derivatives were initially screened against NADPH oxidase enzyme of type 2 (NOX-2) using auto dock vina. Total antioxidant capacity (TAC), total reducing power (TRP) and DPPH assays were used for evaluation of antioxidant capacity through in vitro design of study. Additionally, the anti-inflammatory activity was performed by using carrageenan-induced paw edema test after in silico study against target COX-2. NOX family comprises of seven members NOX-1, NOX-2, NOX-3, NOX-4, NOX-5, DUOX-1 and DUOX-2 (Sorceet al., 2017) . NOX enzymes can result into oxidative tissue damages in a number of diseases such as CNS disorders, diabetic complications and cardiovascular diseases (Fulton and Barman., 2016). The structure of NOX-2 and COX-2 protein was downloaded from protein data bank and active binding sites were identified as shown in Fig. 1  and Fig. 2 respectively. Our methoxy phenol derivatives showed encouraging binding affinities against NOX-2, T2 and T6 having binding affinities -6.2 Kcal/mole and -6.3 Kcal/mole as shown in Table 2 . T2 and T8 also showed good binding affinities against target COX-2 (-7.9 Kcal/mole, -8.0 Kcal/mole) as compared to standard ibuprofen (-6.6 Kcal/mole) as shown in Table 3 . In vitro anti oxidant study also showed encouraging results especially T2 showing IC50value of 25.03 µg/ml as compare to standard ascorbic acid with IC50 value of 15.14 µg/ml (Fig. 7) . T2 and T8 exhibited promising percentage edema inhibition (68.64±3.34, 66.97±2.97) in paw edema test as compared to standard piroxicam showing 83.84±3.87 percentage inhibition (Table 4) .
Our compounds have structural resemblance with eugenol, which is a phenolic compound and main component of clove oil (Gulcin, 2011) . Eugenol decreases the protein oxidation, lipid peroxidation and inflammatory markers in thioacetamide (TA)-induced hepatotoxic rats (Chang et al., 2010) . Other than phenolic ring, benzoic acid ring is also present in our compounds which have also been investigated in many studies to possess antioxidant and anti-inflammatory activity. The presence of phenolic ring, benzoic acid ring and unsaturation in the side chains are making our compounds better antioxidant and anti-inflammatory candidate, producing comparable result to parent compound (Periera et al., 2009) .
Conclusions:
According to the data obtained methoxyphenol derivatives were found to contain effective antioxidant and anti-inflammatory potential. Henceforth, these newly synthesized phenolic derivatives can be considered as effective candidate for further development as potent antioxidant and anti-inflammatory agents.
